Thermo Fisher Scientific Inc (TMO) financial statements and ratios from SEC XBRL: revenue $46.3B (TTM), net margin 15.0%, revenue growth 10.5% YoY, P/E 47.7. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $44.56B |
| Revenue (TTM) | $46.3B |
| Net Margin | 15.0% |
| Return on Equity | 9.5% |
| Operating Margin (TTM) | 17.6% |
| Debt / Equity | 0.80 |
| Current Ratio | 1.55 |
| Net Debt / EBITDA | 3.4 |
| Interest Coverage | 5.6 |
| Revenue Growth (YoY) | 10.5% |
| EPS Growth (YoY) | 9.3% |
| FCF Growth (YoY) | 51.6% |
| P/E Ratio | 47.7 |
| EV / EBITDA | 25.0 |
| Price / Book | 4.53 |
| Price / Sales | 5.15 |
| Dividend Yield | 0.3% |
| FCF Yield | 3.1% |
| Altman Z-Score | 4.05 (safe) |
| Industry P/E (Measuring & Control Equipment) | 43.9 |
| Sector P/E (Technology) | 30.8 |
TMO overview · TMO earnings · TMO KPIs · TMO documents · TMO ownership · TMO peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.